Financial
Informations
Since its inception, Ervaccine Technologies is financially supported by BPIFrance, Cancéropôle Lyon Auvergne-Rhône-Alpes and Agence Nationale de la Recherche.
End of 2020, a life science investor, Seventure (seed investment of 2.5 M€) joined the adventure!